RSS   Newsletter   Contact   Advertise with us

Moleculin Biotech loss $5.0 million

Christian Fernsby ▼ | August 13, 2020
Moleculin Biotech announced its financial results for the quarter ended June 30, 2020.
Moleculin Biotech
Moleculin Biotech   Loss from operations quarter was $5.0 million
Loss from operations for the second quarter was $5.0 million compared to a net loss of $3.6 million for the second quarter of 2019.

Topics: Moleculin Biotech

Net loss for the second quarter of 2020 was $10.1 million, compared to a net loss of $1.2 million in the second quarter of 2019.


 

MORE INSIDE POST